Related Experiment Video
Updated: Mar 2, 2026

07:43
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
11.1K
Pembrolizumab-induced pneumonitis.
Vincent Leroy1, Carole Templier2, Jean-Baptiste Faivre3
1Service de Pneumologie et Immuno-allergologie, Centre de Compétences des Maladies Pulmonaires Rares, CHU Lille, Lille, France.
ERJ Open Research
|May 9, 2017
Summary
Pembrolizumab can cause pneumonitis, a lung inflammation. Two of three described cases presented as organizing pneumonia, a specific type of lung injury.
Area of Science:
- Oncology
- Pulmonology
- Immunology
Background:
- Pembrolizumab is an immune checkpoint inhibitor used in cancer therapy.
- Immune-related adverse events (irAEs) are known side effects of pembrolizumab.
- Pneumonitis is a recognized irAE associated with immune checkpoint inhibitors.
Purpose of the Study:
- To describe clinical cases of pembrolizumab-induced pneumonitis.
- To highlight the specific presentation of organizing pneumonia in two cases.
Main Methods:
- Case report of three patients treated with pembrolizumab.
- Clinical and radiological review of the patients' lung conditions.
Main Results:
- Three patients developed pneumonitis during pembrolizumab therapy.
- Two of these cases exhibited histological and/or radiological features consistent with organizing pneumonia.
Conclusions:
- Pembrolizumab can induce pneumonitis.
- Organizing pneumonia is a potential manifestation of pembrolizumab-induced lung injury.
Related Concept Videos
Pneumonia I: Introduction
1.1K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pneumothorax-II
1.2K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.2K
Pneumothorax-I
1.8K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.8K
Pneumonia III: Complications and Assessment
1.0K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.0K
Pulmonary Embolism I: Introduction
1.0K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.0K

